This is a one-and-a-half-day live and virtual rectal cancer symposium, hosted by Memorial Sloan Kettering Cancer Center, will feature expert faculty from the United States and Europe.
Day 1 includes presentations that will delve into the complexities of choosing between neoadjuvant therapies and operative and non-operative approaches. The day will begin with the Stuart Quan lecture by Dr. Luis Diaz on the use of immunotherapy in CRC. This talk will be followed by sessions on 1) early-stage rectal cancer, 2) upper rectal cancer, 3) mid/lower rectal cancer, and 4) MSI and stage IV rectal cancer. Each session will be accompanied by interactive discussions with thought leaders and attendees.
Day 2 will include sessions with presentations highlighting recent landmark colorectal cancer clinical trials and real-life applications, including Niche, Dynamic, AINKER, and NeoTrial, by their investigators and discussed by expert faculty.
CALL FOR ABSTRACTS
Participants are invited to submit an abstract for presentation at the poster session. Abstracts will be selected on the basis of scientific merit and presentation quality. To submit an abstract for this course, please click on the ‘Abstracts’ link above. A discounted rate is available for authors who submit an abstract. Information will be included in your submission email. Additionally, three $500 travel grants will be awarded, one for each of the following:
Attending’s Choice Award
Best Resident/Fellow Award
People’s Choice Award
Submission Deadline: October 14, 2022